nfluenza
virus
spread
rapidli
caus
widespread
season
epidem
respiratori
diseas
worldwid
result
billion
case
death
annual
annual
usa
million
case
influenza
hospit
death
new
type
influenza
vaccin
provid
longlast
protect
strain
influenza
viru
urgent
need
although
influenza
vaccin
sever
influenza
drug
avail
burden
influenza
societi
remain
enorm
natur
influenza
viru
infect
current
influenza
vaccin
elicit
antibodi
block
bind
head
viral
hemagglutinin
ha
glycoprotein
cell
surfac
receptor
viru
readili
evad
antibodi
mutat
antibodybind
region
figur
contrast
sever
group
recent
identifi
conserv
region
stem
domain
ha
elicit
rare
human
neutral
antibodi
protect
multipl
influenza
ha
subtyp
human
monoclon
antibodi
candid
therapeut
influenza
complex
threedimension
bind
site
monoclon
antibodi
stem
region
ha
extrem
difficult
design
immunogen
mimic
epitop
creat
immunogen
elicit
neutral
antibodi
sequenc
differ
influenza
ha
subtyp
conserv
stem
region
across
differ
ha
subtyp
compar
globular
head
mani
attempt
develop
vaccin
base
stem
domain
subunit
unsuccess
recent
result
suggest
immunogen
provid
cross
protect
sever
strain
within
subtyp
howev
vaccin
still
larg
size
requir
ctermin
trimer
motif
connect
flexibl
linker
properli
fold
trimer
structur
headless
stem
domain
still
remain
shown
crossreact
protect
mani
differ
subtyp
achiev
stem
domain
construct
vivo
challeng
experi
anim
heterolog
subtyp
exist
influenza
vaccin
display
limit
efficaci
sever
reason
head
region
ha
rapidli
mutat
antibodi
human
popul
previou
influenza
strain
select
antigen
variant
new
vaccin
strain
target
variant
must
develop
everi
year
base
predict
viral
strain
may
circul
next
winter
error
left
panel
show
threedimension
structur
trimer
ha
protein
express
recombin
vaccinia
virusinfect
cell
right
panel
show
structur
singl
monom
region
interest
color
red
purpl
respect
head
region
involv
receptor
bind
stem
region
involv
membran
fusion
viru
entri
model
creat
pymol
version
program
phylogenet
tree
hemagglutinin
gene
known
influenza
viru
subtyp
adapt
wu
et
al
categor
ha
molecul
group
two
group
group
color
blue
group
color
red
subtyp
confirm
human
box
platform
technolog
gener
broadli
crossreact
antibodi
predict
antigen
type
long
vaccin
develop
time
compromis
vaccin
program
eighteen
ha
subtyp
influenza
identifi
human
anim
bird
figur
includ
caus
human
pandem
subtyp
influenza
continu
undergo
immun
select
antigen
drift
human
antibodyresist
strain
continu
emerg
caus
new
human
pandem
subtyp
recogn
world
health
organ
potenti
pandem
virus
human
preexist
immun
subtyp
avian
viru
highli
pathogen
human
mortal
rate
human
fortun
effici
humantohuman
transmiss
mutat
viru
gene
alter
antigen
host
rang
increas
viru
virul
transmiss
occur
spontan
genet
engin
creat
biothreat
strain
therefor
new
strategi
need
develop
univers
influenza
vaccin
could
protect
ha
type
antigen
variant
manufactur
quickli
inexpens
stabl
long
selflif
induc
longlast
immun
develop
novel
synthet
peptid
vaccin
platform
technolog
target
ahel
region
protein
chosen
stem
region
class
viral
fusion
protein
influenza
sever
acut
respiratori
syndrom
coronaviru
sarscov
spike
glycoprotein
middl
east
respiratori
syndrom
coronaviru
merscov
spike
glycoprotein
respiratori
syncyti
viru
rsv
f
protein
ebola
glycoprotein
ahel
region
stem
highli
conserv
ideal
candid
vaccin
develop
stem
domain
fusion
glycoprotein
divers
virus
share
common
coiledcoil
structur
must
trigger
undergo
massiv
conform
chang
order
induc
fusion
viru
envelop
host
cell
membran
initi
viru
infect
block
conform
chang
stem
region
viral
fusion
protein
antibodi
prevent
viru
infect
vitro
vivo
thu
one
elicit
antibodi
function
signific
andor
highli
conserv
region
glycoprotein
abil
provid
broadli
protect
vaccin
dramat
enhanc
synthet
peptid
vaccin
mani
advantag
tradit
vaccin
mimic
structur
epitop
found
nativ
protein
target
peptid
vaccin
synthes
soon
viru
emerg
key
region
viral
immunogen
fusion
protein
deduc
viral
nucleic
acid
sequenc
peptid
immunogen
case
small
contain
bcell
epitop
amino
acid
residu
length
rapidli
inexpens
manufactur
larg
quantiti
synthes
peptid
immunogen
purifi
away
cellular
compon
irrelev
viral
protein
tradit
vaccin
intact
protein
may
contain
addit
epitop
elicit
undesir
bcell
tcell
respons
thu
improv
safeti
synthet
peptid
vaccin
amino
acid
sequenc
coiledcoil
region
viral
fusion
protein
highli
conserv
among
mani
strain
emerg
virus
singl
peptid
immunogen
potenti
protect
multipl
subtyp
host
rang
mutant
emerg
viru
make
vaccin
use
human
also
anim
reservoir
viru
uniqu
conformationstabil
templat
twostrand
synthet
peptid
immunogen
highli
stabl
temperatur
facilit
storag
stockpil
vaccin
develop
extrem
simpl
innov
robust
technolog
present
ahel
epitop
nativ
protein
immun
system
result
conformationspecif
antibodi
bind
nativ
protein
target
procedur
involv
process
call
templat
helic
sequenc
interest
insert
parallel
twostrand
ahel
coiledcoil
disulfidebridg
templat
maintain
nativ
helic
conform
epitop
present
surfaceexpos
residu
ahelix
nativ
protein
optim
stabil
immunogen
figur
optim
conform
stabil
immunogen
two
synthet
peptid
stabil
twostrand
coiledcoil
configur
substitut
hydrophob
residu
posit
nativ
ahelix
isoleucin
leucin
respect
also
link
two
templat
peptid
disulfid
bond
well
known
residu
posit
defin
hydrophob
interfac
helic
critic
determin
oligomer
state
stabil
coiledcoil
exampl
bbranch
hydrophob
residu
ile
val
provid
significantli
greater
stabil
coiledcoil
similarli
size
hydrophob
residu
leu
place
posit
wherea
leu
appear
provid
stabil
posit
harburi
et
al
use
synthet
analog
shown
subtl
chang
type
hydrophob
core
residu
result
select
format
dimer
trimer
tetram
structur
hodg
cowork
carri
complet
biophys
character
model
coiledcoil
substitut
differ
amino
acid
residu
posit
posit
determin
effect
protein
stabil
woolfson
alber
develop
algorithm
predict
oligomer
state
coiledcoil
nativ
ahelix
hydrophob
residu
posit
buri
b
c
e
f
g
residu
expos
surfac
similarli
twostrand
ahel
coiledcoil
immunogen
b
c
e
f
g
residu
also
expos
surfac
ident
correspond
residu
display
surfac
select
nativ
ahelix
stem
domain
denot
asterisk
figur
creat
two
helic
surfac
blue
gener
figur
templat
ahel
bcell
epitop
top
panel
show
disulfidebridg
homotwostrand
ahel
coiledcoil
templat
bcell
epitop
residu
posit
b
c
e
f
g
substitut
nativ
bcell
epitop
indic
asterisk
rel
posit
residu
twostrand
coiledcoil
structur
shown
crosssect
view
lower
right
cartoon
lower
left
crosssect
view
direct
helic
page
nh
cooh
terminu
polypeptid
chain
parallel
inregist
heptad
posit
label
ag
prime
indic
correspond
posit
oppos
helix
arrow
depict
hydrophob
interact
occur
residu
cartoon
model
white
circl
denot
b
c
e
f
g
posit
expos
front
view
twostrand
coiledcoil
diagram
templat
peptid
immunogen
use
studi
templat
bcell
epitop
conjug
protein
carrier
keyhol
limpet
hemocyanin
klh
via
linker
consist
gg
spacer
norleucin
quantit
mole
peptid
per
mole
protein
carrier
iodoacetyl
group
use
coupl
peptid
sh
group
klh
disulfid
bond
cterminu
templat
posit
use
stabil
twostrand
ahel
coiledcoil
rr
residu
cterminu
use
enhanc
solubl
immunogen
requir
platform
technolog
gener
broadli
crossreact
antibodi
antibodi
bind
helix
interest
nativ
protein
nativ
trimer
spike
protein
helix
may
singl
ahelix
either
stabil
surround
protein
region
stabil
trimer
coiledcoil
stem
domain
spike
protein
uniqu
technolog
result
antibodi
immunogen
bind
singl
ahel
surfac
dramat
differ
bind
site
monoclon
antibodi
bind
stem
region
hemagglutinin
monoclon
antibodi
bind
site
involv
complex
conform
epitop
rather
singl
helix
materi
method
peptid
synthes
mbha
hydrochlorid
salt
polystyren
resin
substitut
mmole
g
resin
bead
size
mesh
crosslink
divinylbenzen
use
gener
procedur
solidphas
peptid
synthesi
beckman
peptid
synthes
model
amino
acid
coupl
n
atertbutoxycarbonyl
boc
deriv
fivefold
molar
excess
reactiv
sidechain
protect
follow
arg
tosyl
to
asn
xan
asp
cyclohexyl
ochx
cy
mebzl
gln
xan
glu
cyclohexyl
ochx
benzyloxymethyl
bom
ly
ser
benzyl
bzl
thr
benzyl
bzl
trp
formyl
coupl
reaction
perform
use
equival
mixtur
bocamino
acid
bop
benzotriazollyloxytri
dimethylamino
phosphonium
hexafluorophosph
hobt
hydroxybenzotriazol
diea
diisoproylethylamin
dmf
n
ndimethylformamid
min
preactiv
step
coupl
cy
coupl
without
preactiv
prevent
racem
coupl
reaction
monitor
step
use
ninhydrin
kaiser
test
coupl
incomplet
h
recoupl
remov
n
boc
protect
step
accomplish
treatment
min
trifluoroacet
acidch
cl
vv
contain
indol
mg
ml
nh
termin
bocgroup
remov
complet
protect
peptid
hf
cleavag
deprotect
n
iformyltryptophan
carri
use
piperidin
dmf
h
hfcleavag
sidechain
deprotect
peptid
cleavag
resin
carri
use
cleavag
cocktail
consist
hf
anisol
dm
dimethylsulfid
edt
pthiocresol
h
remov
hf
vacuum
crude
free
sulfhydryl
peptid
precipit
ether
filter
dissolv
glacial
acet
acid
lyophil
gave
crude
peptid
white
fluffi
powder
purifi
use
reversedphas
highperform
liquid
chromatographi
rphplc
prepar
reversedphas
hplc
rphplc
carri
luna
c
column
phenomenex
particl
size
pore
size
mm
id
column
equilibr
eluent
eluent
b
eluent
aq
trifluoracet
acid
tfa
eluent
b
tfa
ch
cn
sampl
mg
dissolv
aq
ch
cn
contain
tfa
concentr
mg
ml
load
onto
column
flowrat
ml
min
column
elut
eluent
eluent
b
min
ml
min
follow
shallow
linear
ab
gradient
bmin
ch
cn
fraction
collect
everi
min
subsequ
fraction
analysi
carri
luna
c
rphplc
column
particl
size
pore
size
mm
id
use
linear
ab
gradient
bmin
start
condit
b
puriti
fraction
also
verifi
lc
ms
use
halo
peptid
mm
mm
id
mm
column
advanc
materi
technolog
usa
pool
fraction
contain
purifi
materi
subsequ
lyophil
disulfidebridg
twostrand
peptid
prepar
follow
dithiodipyridin
dtdp
dissolv
dmf
make
final
concentr
lg
ntermin
acetyl
peptid
dissolv
vv
acet
acidh
make
final
concentr
mm
dtdp
solut
ad
peptid
solut
molar
ratio
stir
h
monitor
mass
increas
lcm
distil
water
ad
peptid
thiopyridin
deriv
tp
cystein
purifi
rphplc
tpderiv
peptid
first
strand
peptid
free
cystein
second
strand
dissolv
mm
ammonium
acet
buffer
ph
molar
ratio
stir
h
monitor
mass
chang
lcm
figur
disulfid
bridg
format
complet
disulfidebridg
twostrand
peptid
purifi
rphplc
lyophil
disulfidebridg
twostrand
peptid
purifi
luna
reversedphas
column
phenomenex
mm
particl
size
pore
size
mm
id
column
equilibr
eluent
eluent
b
eluent
aq
tfa
eluent
b
tfa
ch
cn
sampl
mg
depend
yield
crude
sampl
dissolv
aq
ch
cn
contain
tfa
concentr
mg
ml
load
onto
column
flowrat
ml
mm
follow
rapid
gradient
aq
ch
cn
min
final
shallow
gradient
bmin
ch
cn
flow
rate
ml
min
fraction
min
collect
subsequ
analyz
describ
peptid
purif
reversedphas
hplc
section
pool
fraction
contain
purifi
materi
subsequ
lyophil
peptid
immunogen
conjug
keyhol
limpet
hemocyanin
klh
peptid
immunogen
conjug
bovin
serum
albumin
bsa
use
enzymelink
immunosorb
assay
elisa
prepar
follow
singl
free
aamino
group
twostrand
peptid
immunogen
iodoacetyl
use
iodoacet
anhydrid
iodoacet
anhydrid
dissolv
concentr
mm
disulfidebridg
twostrand
peptid
dissolv
mm
nmorpholin
platform
technolog
gener
broadli
crossreact
antibodi
acetonitril
water
tfa
klh
bsaconjug
peptid
purifi
rphplc
lyophil
figur
circular
dichroism
cd
spectra
record
jasco
spectropolarimet
jasco
easton
md
benign
nondenatur
condit
mm
nah
po
na
hpo
mm
kcl
ph
well
presenc
ahelix
induc
solvent
tfe
mm
nah
po
na
hpo
mm
ph
tfe
peptid
ellipt
scan
nm
nm
path
length
cell
temperatur
denatur
measur
follow
chang
molar
ellip
nm
temperatur
increas
rate
min
anim
work
carri
new
england
peptid
accord
establish
protocol
file
briefli
immunogen
two
new
zealand
white
rabbit
immun
use
least
four
subcutan
site
primari
immun
day
contain
lg
klhconjug
peptid
emulsifi
complet
freund
adjuv
cfa
secondari
tertiari
immun
day
day
also
contain
lg
klhconjug
peptid
emulsifi
incomplet
freund
adjuv
ifa
exsanguin
day
serum
collect
store
polyclon
antibodi
precipit
sera
use
ammonium
sulfat
nearli
ml
sera
dilut
pb
crystallin
ammonium
sulfat
ad
satur
g
ml
stir
ice
bath
precipit
immunoglobulin
h
centrifug
min
use
collect
precipit
antibodi
pellet
resuspend
pb
use
volum
start
serum
dialyz
pb
ph
dialysi
solut
chang
least
time
total
dialysi
antibodi
solut
purifi
protein
g
affin
column
cm
id
cm
ml
protein
gsepharos
fast
flow
ge
healthcar
piscataway
nj
bound
antibodi
elut
column
use
ammonium
acet
ph
buffer
solut
immedi
adjust
ph
ammonium
hydroxid
dialyz
pb
overnight
subsequ
antibodi
solut
concentr
mg
ml
amicon
concentr
unit
use
ultrafiltr
disc
millipor
bedford
fulllength
glycosyl
recombin
protein
produc
r
insect
cell
use
baculoviru
express
vector
system
concentr
ha
protein
provid
supplier
base
bicinchonin
acid
colorimetr
assay
determin
total
protein
concentr
solut
want
verifi
concentr
ha
protein
altern
method
sinc
degre
crossreact
ha
protein
depend
concentr
sequenc
ha
protein
carri
quantit
amino
acid
analysi
determin
concentr
method
gave
ident
result
amino
acid
analysi
perform
accord
method
describ
cohen
michaud
briefli
ml
protein
sampl
aliquot
glass
tube
lyophil
tube
ml
hcl
phenol
ad
result
solut
heat
h
order
hydrolyz
peptid
bond
sampl
sampl
tube
allow
come
room
temperatur
vacuumdri
remov
hcl
sampl
resuspend
mm
hcl
ml
sampl
ad
ml
sodium
borat
buffer
ph
mixtur
ml
carbam
acetonitril
ad
derivat
amino
acid
present
sampl
addit
derivat
sampl
heat
min
convert
tyr
byproduct
one
form
highperform
liquid
chromatographi
use
agil
seri
instrument
water
accq
tag
id
mm
column
use
separ
quantifi
derivat
amino
acid
present
sampl
quantif
accomplish
uv
absorb
nm
femal
balbc
mice
divid
experiment
group
mice
one
group
receiv
viru
igg
seven
group
follow
reagent
inocul
intraperiton
one
day
one
day
day
avertin
anesthesia
follow
intranas
challeng
ld
tcid
influenza
viru
phosphat
buffer
salin
pb
mginocul
igg
purifi
protein
g
rabbit
preimmun
serum
preimmun
igg
similarli
purifi
rabbit
immun
klhcoupl
influenza
immunogen
mice
weigh
daili
observ
sign
ill
day
accord
iacuc
protocol
anim
lost
bodi
weight
appear
moribund
immedi
human
euthan
sequenc
obtain
fludborg
use
protein
search
util
search
run
viru
type
ha
classic
protein
ha
protein
sequenc
data
return
protein
host
date
rang
without
specifi
geograph
group
countri
protein
includ
search
along
partial
sequenc
result
sequenc
sequenc
sequenc
filter
appli
sequenc
name
obtain
date
origin
although
filter
date
analys
present
filter
sequenc
ambigu
date
along
chimer
sequenc
download
sequenc
avail
file
obtain
complet
analysi
variabl
full
set
applic
sequenc
wrote
short
program
perl
call
flucheckpl
made
avail
laboratori
web
site
wwwevolutionarygenomicscom
aim
analysi
show
variabl
short
sequenc
fragment
kmer
posit
alignmentfre
analysi
kmer
posit
rel
one
anoth
program
paramet
adjust
control
file
relev
paramet
minimum
kmer
count
consid
also
minimum
transit
count
consid
obtain
rel
posit
dataset
set
dataset
far
fewer
sequenc
set
note
highest
kmer
count
vari
along
sequenc
primarili
sequenc
fulllength
kmer
length
analys
seven
ie
avoid
long
costli
process
trial
error
select
ahel
bcell
epitop
vaccin
develop
method
need
rapidli
identifi
deduc
amino
acid
sequenc
key
ahel
bcell
epitop
residu
would
optim
vaccin
candid
develop
novel
comput
technolog
call
stablecoil
select
stabl
amphipath
ahelic
protein
potenti
form
stabl
coiledcoil
structur
stablecoil
base
entir
experiment
determin
physiochem
paramet
paramet
includ
stabil
coeffici
deriv
model
coiledcoil
ahel
propens
valu
deriv
synthet
amphipath
ahel
peptid
consid
protein
sequenc
interest
seven
possibl
read
frame
repeat
heptad
sequenc
abcdefg
n
found
stablecoil
consid
seven
possibl
read
frame
gener
predict
stabil
data
one
result
stablecoil
avoid
need
screen
larg
number
vaccin
construct
defin
read
frame
contain
predict
coiledcoil
sequenc
indic
residu
belong
posit
heptad
repeat
abcdefg
n
stablecoil
rapidli
identifi
region
interest
thu
reduc
number
bcell
epitop
must
studi
experiment
stablecoil
predict
amphipath
ahelic
produc
neutral
antibodi
import
greatli
reduc
number
helic
epitop
potenti
vaccin
candid
emphas
first
report
stablecoil
use
algorithm
identifi
two
heptad
repeat
region
hrn
hrc
spike
glycoprotein
sarscoronaviru
use
templat
twostrand
coiledcoil
technolog
elicit
neutral
antibodi
sarscoronaviru
present
updat
stablecoil
make
avail
worldwid
complet
turn
emerg
reemerg
virus
enter
cell
use
class
viral
fusion
protein
stabl
amphipath
ahelic
capabl
form
coiledcoil
structur
ahelic
involv
major
conform
chang
induc
fusion
viru
envelop
host
cell
membran
initi
viru
entri
initi
goal
project
show
could
take
helic
amino
acid
sequenc
trimer
hemagglutinin
ha
protein
insert
conformationstabil
twostrand
ahel
coiledcoil
templat
use
immunogen
gener
polyclon
antibodi
rabbit
bound
nativ
ha
protein
twostrand
disulfidebridg
immunogen
conjug
carrier
protein
keyhol
limpet
hemocyanin
klh
immun
rabbit
bovin
serum
albumin
bsa
screen
sera
antibodi
product
peptid
immunogen
figur
figur
helic
region
stem
ha
investig
denot
color
red
purpl
respect
figur
show
result
antibodi
gener
sequenc
ha
denot
sequenc
ha
puerto
sinai
denot
insert
disulfidebridg
twostrand
ahel
coiledcoil
templat
case
sequenc
disulfidebridg
locat
ntermin
case
sequenc
disulfidebridg
locat
cterminu
sequenc
interest
coiledcoil
templat
replac
nativ
hydrophob
core
residu
posit
ile
posit
leu
posit
chang
stabil
result
coiledcoil
structur
ensur
coiledcoil
twostrand
disulfidebridg
two
strand
stabil
twostrand
coiledcoil
immunogen
previous
demonstr
contribut
disulfid
bond
protein
stabil
depend
whether
disulfid
bond
posit
hydrophob
core
coiledcoil
disulfid
bond
posit
nearoptim
geometri
make
largest
contribut
coiledcoil
stabil
posit
contribut
significantli
coiledcoil
stabil
disulfid
bond
insert
ntermin
increas
stabil
similar
posit
c
termin
end
coiledcoil
also
show
hydrophob
interact
posit
less
import
end
coiledcoil
end
coiledcoil
flexibl
thu
disulfidebond
end
coiledcoil
prevent
endfray
stabil
coiledcoil
structur
helic
conform
end
twostrand
coiledcoil
better
mimick
helicalstructur
nativ
protein
immunogen
coupl
protein
carrier
keyhol
limpet
hemocyanin
klh
use
immun
rabbit
figur
result
igg
purifi
rabbit
sera
evalu
bind
crossreact
ha
protein
five
influenza
viru
subtyp
group
group
case
immunogen
antibodi
specif
signific
bind
ha
figur
result
show
extens
sequenc
residu
enhanc
crossreact
antibodi
group
sequenc
repres
sequenc
align
clearli
show
antibodi
crossreact
group
sequenc
repres
figur
sequenc
differ
group
group
dramat
region
result
also
show
sequenc
ident
two
heptad
enough
gener
crossreact
antibodi
haprotein
indic
green
highlight
figur
figur
show
result
antibodi
crossreact
two
immunogen
region
antibodi
gener
immunogen
cover
nativ
sequenc
region
demonstr
crossreact
group
group
haprotein
group
group
antibodi
show
crossreact
ha
protein
group
extens
sequenc
result
sequenc
greater
sequenc
ident
indic
green
shade
area
figur
result
show
sequenc
ident
figur
rabbit
immun
three
time
peptideklh
conjug
use
freund
adjuv
rabbit
igg
prepar
preand
postimmun
sera
use
passiv
immun
balbc
mice
day
mgip
inocul
mice
challeng
intranas
ld
pr
viru
day
jiang
et
al
immunogen
group
group
enough
gener
antibodi
crossreact
group
ha
protein
repres
subtyp
result
demonstr
one
immunogen
gener
crossreact
antibodi
bind
group
group
haprotein
thu
show
potenti
univers
synthet
peptid
vaccin
interest
abl
add
two
addit
arg
residu
cterminu
immunogen
sequenc
solubl
enhanc
residu
without
prevent
gener
crossreact
antibodi
nativ
ha
protein
antibodi
bind
studi
ha
protein
want
know
glycosyl
ha
protein
would
affect
antibodi
bind
address
concern
use
hemagglutinin
influenza
viru
asolomon
full
length
glycosyl
recombin
protein
produc
insect
cell
use
baculoviru
express
vector
system
shown
figur
antibodi
bind
fulli
glycosyl
protein
solomon
island
nglycosyl
site
influenza
virus
determin
stem
region
residu
glycosyl
highli
conserv
distant
antibodi
bind
region
analysi
ha
sequenc
human
viru
isol
reveal
gradual
increas
glycosyl
time
specif
glycosyl
site
respons
virul
antigen
properti
identifi
fortun
glycosyl
seem
leav
region
interest
vaccin
untouch
probabl
glycosyl
would
prevent
region
undergo
conform
chang
necessari
membran
fusion
viru
entri
want
learn
whether
antibodi
bind
ha
protein
would
also
protect
mice
viru
challeng
carri
passiv
immun
mice
rabbit
antibodi
immunogen
shown
figur
result
figur
show
passiv
immun
antibodi
protect
mice
intranas
challeng
ld
influenza
viru
pr
taken
togeth
elisa
crossreact
mous
protect
data
suggest
vaccin
would
like
provid
broad
crossprotect
multipl
influenza
strain
antigen
variant
differ
subtyp
ha
carri
detail
analysi
hemagglutinin
sequenc
figur
show
plot
kmer
variant
count
versu
sequenc
posit
stem
domain
region
figur
acquisit
analysi
hemagglutinin
sequenc
sequenc
stem
region
residu
result
panel
b
c
show
variabl
short
sequenc
fragment
kmer
sequenc
posit
kmer
length
analys
seven
ie
mer
see
method
section
acquisit
analysi
hemagglutinin
sequenc
detail
two
region
studi
synthet
peptid
vaccin
develop
denot
green
brown
respect
platform
technolog
gener
broadli
crossreact
antibodi
figur
region
compar
identifi
sequenc
sequenc
highest
occurr
region
occurr
sequenc
indic
blue
shade
sequenc
denot
conserv
substitut
eg
kr
im
li
iv
yf
ns
red
shade
denot
nonconserv
substitut
eg
sf
sl
kn
includ
sequenc
occurr
jiang
et
al
locat
sequenc
color
green
brown
frequenc
occurr
sequenc
identifi
analysi
shown
figur
region
one
sequenc
identifi
repres
sequenc
identifi
occurr
greater
region
one
sequenc
identifi
frequenc
occurr
region
ten
sequenc
observ
frequenc
occurr
one
sequenc
occur
time
repres
occurr
region
slightli
variabl
major
sequenc
frequenc
occurr
repres
occurr
region
one
sequenc
repres
occurr
region
three
sequenc
repres
occurr
sequenc
remain
highli
conserv
spanish
flu
pandem
present
subtl
substitut
conserv
residu
eg
mi
li
vi
fy
rk
sequenc
essenti
ident
present
similarli
sequenc
extrem
conserv
sinc
present
major
chang
observ
k
r
r
k
substitut
base
sequenc
inform
easi
understand
antibodi
crossreact
singl
peptid
immunogen
helic
involv
major
conform
chang
necessari
membran
fusion
viru
entri
clear
sequenc
remain
highli
conserv
time
exist
trival
vaccin
consist
three
ha
protein
two
influenza
one
influenza
b
antigen
variant
three
protein
global
circul
sinc
goal
select
best
sequenc
region
provid
immun
respons
human
antibodi
protect
viral
strain
group
group
templat
disulfidebridg
twostrand
peptid
immunogen
complet
helic
aqueou
condit
signific
ahel
structur
induc
addit
helix
induc
solvent
trifluoroethanol
figur
temperatur
denatur
show
temperatur
midpoint
unfold
demonstr
except
stabil
immunogen
figur
b
templat
peptid
immunogen
technolog
provid
highli
structur
stabl
peptid
immunogen
ahel
conform
toler
wide
varieti
sequenc
technolog
elicit
antibodi
crossreact
ha
protein
subtyp
ahel
region
stem
domain
involv
membran
fusion
viru
entri
templat
design
maximum
stabil
creat
hydrophob
core
consist
ile
posit
leu
posit
interchain
disulfidebridg
posit
end
coiledcoil
chang
also
lock
immunogen
twostrand
coiledcoil
structur
interest
ahelic
twostrand
structur
gener
antibodi
bind
ahelic
nativ
hemagglutinin
threestrand
coiledcoil
stem
domain
design
greatli
simplifi
immunogen
structur
technolog
leav
five
everi
seven
residu
surfaceexpos
mimic
nativ
amphipath
ahelix
nativ
protein
research
suggest
bcell
figur
circular
dichroism
spectroscopi
cd
result
templat
disulfidebridg
peptid
immunogen
panel
show
cd
spectra
peptid
immunogen
aqueou
benign
buffer
ph
mm
sodium
phosphat
buffer
mm
kcl
ph
open
symbol
buffer
contain
helixinduc
solvent
trifluoroethanol
close
symbol
panel
b
show
temperatur
denatur
curv
temperatur
increas
templat
twostrand
ahel
coiledcoil
disulfidebridg
platform
technolog
gener
broadli
crossreact
antibodi
epitop
ideal
gener
conformationspecif
antibodi
also
discov
subtl
chang
design
peptid
immunogen
dramat
effect
crossreact
result
antibodi
exampl
shown
immunogen
figur
extend
sequenc
immunogen
nterminu
reposit
disulfid
bond
nterminu
cterminu
immunogen
subtl
chang
sequenc
chang
antibodi
crossreact
specif
figur
antibodi
crossreact
three
group
ha
protein
includ
figur
similarli
compar
immunogen
figur
extend
sequenc
ctermin
residu
reposit
disulfid
bond
ntermin
immunogen
cterminu
immunogen
show
best
crossreact
group
ha
protein
chang
improv
crossreact
hemagglutinin
